These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 11363236

  • 1. New treatment for KS offers options for therapy.
    AIDS Alert; 1996 Feb; 11(2):21-2. PubMed ID: 11363236
    [Abstract] [Full Text] [Related]

  • 2. FDA approves KS drug. Food and Drug Administration. Florida Department of Health and Rehabilitation Services.
    AIDS Alert; 1996 Jan; 11(1):11-2. PubMed ID: 11363227
    [Abstract] [Full Text] [Related]

  • 3. KS treatment inches forward.
    Vazquez E.
    Posit Aware; 1996 Jan; 7(5):9. PubMed ID: 11363790
    [Abstract] [Full Text] [Related]

  • 4. DOXIL superior for KS.
    Posit Aware; 1995 Jan; ():7. PubMed ID: 11362576
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Liposomal KS drugs approved.
    GMHC Treat Issues; 1996 Apr; 10(4):8-9. PubMed ID: 11363710
    [Abstract] [Full Text] [Related]

  • 10. Liposomal doxorubicin: new preparation. Useful in Kaposi's sarcoma.
    Prescrire Int; 1998 Jun; 7(35):69-70. PubMed ID: 10342919
    [Abstract] [Full Text] [Related]

  • 11. [Kaposi's sarcoma].
    Imamura A.
    Gan To Kagaku Ryoho; 2003 May; 30(5):634-9. PubMed ID: 12795094
    [Abstract] [Full Text] [Related]

  • 12. The response of symptomatic gastrointestinal Kaposi's sarcoma to chemotherapy: a prospective evaluation using an endoscopic method of disease quantification.
    Laine L, Amerian J, Rarick M, Harb M, Gill PS.
    Am J Gastroenterol; 1990 Aug; 85(8):959-61. PubMed ID: 1695812
    [Abstract] [Full Text] [Related]

  • 13. Kaposi's sarcoma: DaunoXome approved.
    AIDS Treat News; 1996 May 03; (no 246):3-4. PubMed ID: 11363485
    [Abstract] [Full Text] [Related]

  • 14. Liposomal chemotherapies.
    Smart T.
    GMHC Treat Issues; 1995 May 03; 9(7/8):13. PubMed ID: 11362653
    [Abstract] [Full Text] [Related]

  • 15. DOXIL approved for KS.
    James JS.
    AIDS Treat News; 1995 Dec 01; (no 236):6. PubMed ID: 11363051
    [Abstract] [Full Text] [Related]

  • 16. FDA approves DaunoXome as first-line therapy for Kaposi's sarcoma. Food and Drug Administration.
    J Int Assoc Physicians AIDS Care; 1996 May 01; 2(5):50-1. PubMed ID: 11363534
    [Abstract] [Full Text] [Related]

  • 17. KS update.
    Notes Undergr; 1995 May 01; (no 29):4. PubMed ID: 11362282
    [Abstract] [Full Text] [Related]

  • 18. Kaposi's sarcoma: DOX-SL approval recommended.
    AIDS Treat News; 1995 Feb 17; (no 217):8. PubMed ID: 11362308
    [Abstract] [Full Text] [Related]

  • 19. Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group.
    Stewart S, Jablonowski H, Goebel FD, Arasteh K, Spittle M, Rios A, Aboulafia D, Galleshaw J, Dezube BJ.
    J Clin Oncol; 1998 Feb 17; 16(2):683-91. PubMed ID: 9469358
    [Abstract] [Full Text] [Related]

  • 20. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.
    Gill PS, Wernz J, Scadden DT, Cohen P, Mukwaya GM, von Roenn JH, Jacobs M, Kempin S, Silverberg I, Gonzales G, Rarick MU, Myers AM, Shepherd F, Sawka C, Pike MC, Ross ME.
    J Clin Oncol; 1996 Aug 17; 14(8):2353-64. PubMed ID: 8708728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.